HOME >> MEDICINE >> NEWS
UK plans for pandemic flu don't go far enough

The UK's contingency plans for pandemic flu don't go far enough, argues a director of public health in this week's BMJ.

Plans for pandemic flu in the United Kingdom are said to be among the best in the developed world, but important lessons from the past have been missed, writes Hilary Pickles. These include the need to prepare for high death rates, being open with the public, and understanding population behaviour. Clear and appropriate accountability and communications are also needed, she concludes.

In response, David Salisbury, Director of Immunisation at the Department of Health, argues that preparedness has been strengthened through cross government working, enhanced communications, and international cooperation.

In a second article, public health experts in Belgium discuss the risks of a pandemic and ask whether stockpiling antiviral drugs is the best response. They argue that, in a climate of fear, the perception of risk is easily distorted from the actual risk, making us over-react to hypothetical dangers. This has led to stockpiling of antiviral drugs of no clear use, and following mindlessly the advice of disease experts with undeniable interests.

They believe that the energy unleashed by the fear of a pandemic should be directed at tackling real health problems.

"Intensive care resources are unlikely to be able to meet the extra demand of an influenza pandemic, warns critical care specialist, Richard Marsh. Based on data from influenza patients admitted to hospital in Asia, he predicts that between four and five times the number of intensive care beds available in most general hospitals in the UK would be required to meet demand at the peak of the epidemic.

Decisions will be difficult and will require an unprecedented degree of cooperation between everyone caring for these patients, he concludes.

In terms of primary care, preparation is key, says Anthony Harnden. It is not sufficient for practices t
'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-207-383-6529
BMJ-British Medical Journal
30-Mar-2006


Page: 1 2

Related medicine news :

1. Research probes seniors plans for end-of-life care
2. Comparison of 4 diet plans shows better outcomes for diet with lowest carbohydrate intake
3. Consumer-driven health plans slow to catch on, 2nd annual survey finds
4. Extra payments to Medicare Advantage plans totaled $5.2 billion over fee-for-service costs in 2005
5. Specific strategic plans ensure timely emergency care for heart attack patients
6. Racial disparities high in Medicare plans
7. Medicare Advantage plans not always a good deal
8. Study highlights gaps in Europes preparedness plans for pandemic influenza
9. UK plans to cut street prostitution will threaten sex workers health
10. Health care plans for Medicare beneficiaries are not all alike
11. Government plans for NHS more aggressive than Tories ever were

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: plans for pandemic flu don far enough

(Date:10/22/2014)... October 22, 2014 Lintelus, Inc., an ... Vice President of Sales, will be speaking on the ... Technology Expo on October 28, at the Holiday Inn ... a booth as well as a Tech Demo at ... can create a more engaging event experience. , The ...
(Date:10/22/2014)... October 22, 2014 Akeso Biomedical, ... for the treatment of bacterial infections, microbial biofilms, and ... joined its board of directors. , Dr. ... Systems at The Massachusetts Institute of Technology, or MIT. ... since 1968. Dr. Sinskey also holds positions as Co-Director ...
(Date:10/22/2014)... Maureen Salamon HealthDay Reporter ... undergoing in vitro fertilization (IVF) are only about half as ... assisted reproduction technique, new research indicates, and the racial disparity ... study, about 31 percent of white patients became pregnant after ... Analyzing more than 4,000 IVF cycles over two years to ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 (HealthDay ... to increased blood pressure, according to a new study. ... pressure for young adult women or for teenagers, according to ... or moderately, their risk of high blood pressure was cut ... in older adult men and women," said lead researcher Dr. ...
(Date:10/22/2014)... Measures taken by Firestone officials at the company,s ... the spread of the disease there and could prove ... Co. provides health services to about 80,000 employees, retirees, ... Between Aug. 1 and Sept. 23, there were ... people. That incidence rate of 0.09 percent was much ...
Breaking Medicine News(10 mins):Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2
(Date:10/22/2014)... JOLLA, Calif. , Oct. 22, 2014 ... RGLS ), a biopharmaceutical company leading the ... microRNAs, today announced that it has demonstrated ... an ongoing clinical study evaluating RG-101, a ... the treatment of hepatitis C virus infection ...
(Date:10/20/2014)... , 20 de octubre de 2014  PneumRx, ... campo de la pulmonología intervencional, anunció hoy la ... casi 3 meses antes de lo programado. El Estudio ... de dispositivo de investigación (IDE) aprobada por la ... sistema de espiral de reducción de volumen pulmonar ...
(Date:10/20/2014)... 20, 2014  ResMed (NYSE: RMD ... Data Exchange program, a comprehensive suite of software ... and other health care providers. ... critical patient information. It integrates valuable sleep and ... patient management platforms with customers, in-house or third-party ...
Breaking Medicine Technology:A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8PneumRx concluye inscripción en prueba fundamental RENEW 2PneumRx concluye inscripción en prueba fundamental RENEW 3ResMed Launches ResMed Data Exchange 2
Cached News: